Melodiol Global Health (AU:ME1) has released an update.
Melodiol Global Health Limited has successfully completed a consolidation of its issued capital, where 1 security has been consolidated for every 30 previously existing securities, as approved by shareholders. The restructuring reflects a revised balance of various securities, including ordinary shares, listed options, and performance rights, aiming to streamline the company’s capital structure. Melodiol, known for its plant-based health products, continues to strive for quality and broad consumer reach in its offerings.
For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.
